Table of Content

1. Market Introduction and Scope
1.1. Objectives of the Report
1.2. Report Coverage & Definitions
1.3. Report Scope
2. Executive Insights and Key Takeaways
2.1. Market Highlights and Strategic Takeaways
2.2. Key Trends and Future Projections
2.3. Snippet by Disease Type
2.4. Snippet by Treatment Modality
2.5. Snippet by Application
2.6. Snippet by End-User
2.7. Snippet by Region
3. Dynamics
3.1. Impacting Factors
3.1.1. Drivers
3.1.1.1. Rising Therapeutic Advancements for Pleural Effusions
3.1.2. Restraints
3.1.2.1. Risk of Complications and Recurrence
3.1.3. Opportunity
3.1.4. Impact Analysis
4. Strategic Insights and Industry Outlook
4.1. Market Leaders and Pioneers
4.1.1. Emerging Pioneers and Prominent Players
4.1.2. Established leaders with largest selling Brand
4.1.3. Market leaders with established Product
4.2. CXO Perspectives
4.3. Latest Developments and Breakthroughs
4.4. Case Studies/Ongoing Research
4.5. Regulatory and Reimbursement Landscape
4.5.1. North America
4.5.2. Europe
4.5.3. Asia Pacific
4.5.4. Latin America
4.5.5. Middle East & Africa
4.6. Porter’s Five Force Analysis
4.7. Supply Chain Analysis
4.8. Patent Analysis
4.9. SWOT Analysis
4.10. Unmet Needs and Gaps
4.11. Recommended Strategies for Market Entry and Expansion
4.12. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
4.13. Pricing Analysis and Price Dynamics
5. Pleural Effusions Treatment Market, By Disease Type
5.1. Introduction
5.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Type
5.1.2. Market Attractiveness Index, By Disease Type
5.2. Transudative Pleural Effusions*
5.2.1. Introduction
5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
5.3. Exudative Pleural Effusions
6. Pleural Effusions Treatment Market, By Treatment Modality
6.1. Introduction
6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment Modality
6.1.2. Market Attractiveness Index, By Treatment Modality
6.2. Thoracentesis*
6.2.1. Introduction
6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Tube Thoracostomy
6.4. Pleurodesis
6.5. Pleural Decortication
6.6. Pleuroperitoneal Shunt
6.7. Catheter Placement
6.8. Others
7. Pleural Effusions Treatment Market, By Application
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
7.1.2. Market Attractiveness Index, By Application
7.2. Malignant Pleural Effusions*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Paramalignant Pleural Effusions
8. Pleural Effusions Treatment Market, By End-User
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
8.1.2. Market Attractiveness Index, By End-User
8.2. Hospitals*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Ambulatory Surgery Centers
8.4. Specialty Clinics
8.5. Homecare Settings
8.6. Others
9. Pleural Effusions Treatment Market, By Regional Market Analysis and Growth Opportunities
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
9.1.2. Market Attractiveness Index, By Region
9.2. North America
9.2.1. Introduction
9.2.2. Key Region-Specific Dynamics
9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Type
9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment Modality
9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
9.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.2.7.1. U.S.
9.2.7.2. Canada
9.2.7.3. Mexico
9.3. Europe
9.3.1. Introduction
9.3.2. Key Region-Specific Dynamics
9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Type
9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment Modality
9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
9.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.3.7.1. Germany
9.3.7.2. U.K.
9.3.7.3. France
9.3.7.4. Spain
9.3.7.5. Italy
9.3.7.6. Rest of Europe
9.4. South America
9.4.1. Introduction
9.4.2. Key Region-Specific Dynamics
9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Type
9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment Modality
9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
9.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.4.7.1. Brazil
9.4.7.2. Argentina
9.4.7.3. Rest of South America
9.5. Asia-Pacific
9.5.1. Introduction
9.5.2. Key Region-Specific Dynamics
9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Type
9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment Modality
9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
9.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.5.7.1. China
9.5.7.2. India
9.5.7.3. Japan
9.5.7.4. South Korea
9.5.7.5. Rest of Asia-Pacific
9.6. Middle East and Africa
9.6.1. Introduction
9.6.2. Key Region-Specific Dynamics
9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Type
9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment Modality
9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10. Competitive Landscape and Market Positioning
10.1. Competitive Overview and Key Market Players
10.2. Market Share Analysis and Positioning Matrix
10.3. Strategic Partnerships, Mergers & Acquisitions
10.4. Key Developments in Product Portfolios and Innovations
10.5. Company Benchmarking
11. Company Profiles
11.1. B. Braun SE*
11.1.1. Company Overview
11.1.2. Product Portfolio and Description
11.1.3. Financial Overview
11.1.4. Key Developments
11.1.5. SWOT Analysis
11.2. Becton, Dickinson and Company
11.3. Bearpac Medical, LLC.
11.4. Redax S.p.a.
11.5. Rocket Medical
11.6. PFM Medical, Inc.
11.7. Cook Medical Inc.
11.8. Boston Medical Products Inc.
11.9. Pfizer Inc.
11.10. Grena Limited
LIST NOT EXHAUSTIVE
12. Assumption and Research Methodology
12.1. Data Collection Methods
12.2. Data Triangulation
12.3. Forecasting Techniques
12.4. Data Verification and Validation
13. Appendix
13.1. About Us and Services
13.2. Contact Us